A fentanyl vaccine developed by Scripps Research has entered Phase I human trials after reducing brain opioid levels by 70% in animals, with researchers saying it could protect against designer variants too.
Browsing: clinical trials
A fentanyl vaccine developed by Scripps Research has entered Phase I human trials after reducing brain opioid levels by 70% in animals, with researchers saying it could protect against designer variants too.